Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
| 1263 | 2 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//BISPECIFIC ANTIBODY | 9152 |
| 8446 | 1 | BISPECIFIC ANTIBODY//BISPECIFIC ANTIBODIES//BISPECIFIC | 1283 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BISPECIFIC ANTIBODY | authKW | 2552799 | 15% | 54% | 191 |
| 2 | BISPECIFIC ANTIBODIES | authKW | 1135992 | 7% | 50% | 93 |
| 3 | BISPECIFIC | authKW | 593521 | 3% | 58% | 42 |
| 4 | DIABODY | authKW | 469171 | 3% | 47% | 41 |
| 5 | CATUMAXOMAB | authKW | 462825 | 2% | 61% | 31 |
| 6 | TRIFUNCTIONAL ANTIBODY | authKW | 440312 | 2% | 81% | 22 |
| 7 | BISPECIFIC MONOCLONAL ANTIBODY | authKW | 307552 | 2% | 52% | 24 |
| 8 | TRIABODY | authKW | 245633 | 1% | 100% | 10 |
| 9 | BISPECIFIC DIABODY | authKW | 240712 | 1% | 70% | 14 |
| 10 | QUADROMA | authKW | 165798 | 1% | 75% | 9 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 5477 | 35% | 0% | 445 |
| 2 | Immunology | 5397 | 32% | 0% | 405 |
| 3 | Medicine, Research & Experimental | 1362 | 13% | 0% | 169 |
| 4 | Biochemical Research Methods | 799 | 9% | 0% | 117 |
| 5 | Biotechnology & Applied Microbiology | 719 | 11% | 0% | 145 |
| 6 | Hematology | 382 | 6% | 0% | 77 |
| 7 | Biochemistry & Molecular Biology | 351 | 18% | 0% | 227 |
| 8 | Pharmacology & Pharmacy | 52 | 6% | 0% | 83 |
| 9 | Cell Biology | 30 | 5% | 0% | 60 |
| 10 | Biophysics | 29 | 3% | 0% | 37 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CLIN COOPERAT GRP BISPECIF ANTIBODIES | 122816 | 0% | 100% | 5 |
| 2 | ADELE R DECOF CANC | 88423 | 0% | 60% | 6 |
| 3 | CELL OURCE BIOMED | 71835 | 1% | 21% | 14 |
| 4 | LARGE MOL | 56125 | 1% | 19% | 12 |
| 5 | RECOMBINANT ANTIBODY GRP D0500 | 55266 | 0% | 75% | 3 |
| 6 | RECOMBINANT ANTIBODY GRP | 38373 | 0% | 31% | 5 |
| 7 | ABDOMINAL VASC TRANSPLANT SURG | 35362 | 0% | 24% | 6 |
| 8 | IMMUNOTHER Y TREATMENT | 27630 | 0% | 38% | 3 |
| 9 | ABDOMNEL VASC TRANSPLANT SURG | 24563 | 0% | 100% | 1 |
| 10 | ABRAMSON CANC SMILOW | 24563 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MABS | 118804 | 5% | 8% | 62 |
| 2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 25534 | 5% | 2% | 68 |
| 3 | PROTEIN ENGINEERING DESIGN & SELECTION | 8942 | 2% | 2% | 20 |
| 4 | TUMOR TARGETING | 7618 | 0% | 10% | 3 |
| 5 | JOURNAL OF IMMUNOTHERAPY | 7576 | 2% | 1% | 23 |
| 6 | IMMUNOTECHNOLOGY | 7015 | 0% | 14% | 2 |
| 7 | JOURNAL OF IMMUNOLOGICAL METHODS | 6514 | 4% | 1% | 51 |
| 8 | INTERNATIONAL JOURNAL OF CANCER | 5795 | 5% | 0% | 70 |
| 9 | HYBRIDOMA | 2605 | 1% | 1% | 15 |
| 10 | JOURNAL OF IMMUNOLOGY | 1891 | 5% | 0% | 66 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BISPECIFIC ANTIBODY | 2552799 | 15% | 54% | 191 | Search BISPECIFIC+ANTIBODY | Search BISPECIFIC+ANTIBODY |
| 2 | BISPECIFIC ANTIBODIES | 1135992 | 7% | 50% | 93 | Search BISPECIFIC+ANTIBODIES | Search BISPECIFIC+ANTIBODIES |
| 3 | BISPECIFIC | 593521 | 3% | 58% | 42 | Search BISPECIFIC | Search BISPECIFIC |
| 4 | DIABODY | 469171 | 3% | 47% | 41 | Search DIABODY | Search DIABODY |
| 5 | CATUMAXOMAB | 462825 | 2% | 61% | 31 | Search CATUMAXOMAB | Search CATUMAXOMAB |
| 6 | TRIFUNCTIONAL ANTIBODY | 440312 | 2% | 81% | 22 | Search TRIFUNCTIONAL+ANTIBODY | Search TRIFUNCTIONAL+ANTIBODY |
| 7 | BISPECIFIC MONOCLONAL ANTIBODY | 307552 | 2% | 52% | 24 | Search BISPECIFIC+MONOCLONAL+ANTIBODY | Search BISPECIFIC+MONOCLONAL+ANTIBODY |
| 8 | TRIABODY | 245633 | 1% | 100% | 10 | Search TRIABODY | Search TRIABODY |
| 9 | BISPECIFIC DIABODY | 240712 | 1% | 70% | 14 | Search BISPECIFIC+DIABODY | Search BISPECIFIC+DIABODY |
| 10 | QUADROMA | 165798 | 1% | 75% | 9 | Search QUADROMA | Search QUADROMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
| rank | cluster_id2 | link |
|---|---|---|
| 1 | 16318 | EPCAM//TROP2//EP CAM |
| 2 | 4756 | CANONICAL STRUCTURES//HUMANIZATION//ANTIBODY ENGINEERING |
| 3 | 35594 | KILLERRED//MINISOG//PL FUNDAMENTAL MED |
| 4 | 6417 | PHAGE DISPLAY//ANTIBODY LIBRARY//SCFV |
| 5 | 19515 | PRETARGETING//PRETARGETED RADIOIMMUNOTHERAPY//AVIDINOX |
| 6 | 35429 | BIFUNCTIONAL FUSION ENZYME//END TO END FUSION//XYLOSIDASE ARABINOSIDASE |
| 7 | 12218 | CD20//RITUXIMAB//OBINUTUZUMAB |
| 8 | 14033 | NANOBODY//SINGLE DOMAIN ANTIBODY//VHH |
| 9 | 15016 | GD2//CH1418//GD2 GANGLIOSIDE |
| 10 | 31800 | TGN1412//CYTOKINE RELEASE ASSAY//TAB08 |